Anti-E1Anti-E2 rE1E2p7 protein VEE/SIN-E1E2P7 VEE/SIN-E1E2 33-35 rE1E2P7 protein VEE/SIN-E1E2P7 VEE/SIN-E1E2 EndoH 35 25 15 75 50 35 25 r E1E2p7 protein)

Slides:

Advertisements

Similar presentations

Supplementary Table 1. Immunological Characteristics of Patients.

Advertisements

Nuclear-free preparation Control Nuclear-free preparation DMSO Whole cell preparation Control Whole cell preparation DMSO 66 kD Supplementary Fig. 1. Western.

Α-A26-39 rA26-39 rB ~ 270 kDa rB15-24 rA α-B ~ 308 kDa Supp. Figure 1: Toxins.

Pp65-specific all B: CD8 T-cells CD8/pp65 T cells per ml blood A: CD8 T-cells Indicated memory subset as a proportion of the reference T-cell subset FIG.

Key Variables in ICS Assays

HCV Assays: Impact on HCV Studies & Update on HCV blood bank protocol.

Fig. 1. Antibody response in mice immunized with VLP. Three groups of mice (n=10/group) were used in this study. Mice in groups 1 and 2 were immunized.

c-Myc expression in response to pre-TCR stimulation.

DNAM-1 Expression Marks an Alternative Program of NK Cell Maturation

Regulation of TH2 responses by the pulmonary Clara cell secretory 10-kd protein Chih-Hsing Hung, MD, Li-Chen Chen, MD, Zhongjian Zhang, PhD, Bhabadeb.

Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man Immunity

Volume 5, Issue 1, Pages (January 2009)

Cyclophosphamide induces type I interferon and augments the number of CD44hi T lymphocytes in mice: implications for strategies of chemoimmunotherapy of.

Ting-ting Zhang, MSc, Klaus Okkenhaug, PhD, Baher F

CpG oligodeoxynucleotides allow for effective adoptive T-cell therapy in chronic retroviral infection by Anke R. M. Kraft, Frank Krux, Simone Schimmer,

Volume 143, Issue 4, Pages e9 (October 2012)

Accelerated Migration of Respiratory Dendritic Cells to the Regional Lymph Nodes Is Limited to the Early Phase of Pulmonary Infection Kevin L Legge,

Volume 16, Issue 2, Pages (February 2002)

Volume 25, Issue 11, Pages (November 2017)

Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission Yongjun Tian,

Human osteoarthritic chondrocytes are impaired in matrix metalloproteinase-13 inhibition by IFN-γ due to reduced IFN-γ receptor levels R. Ahmad, M. El.

Vaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing.

Volume 143, Issue 6, Pages e4 (December 2012)

Volume 22, Issue 5, Pages (May 2014)

Volume 18, Issue 5, Pages (May 2003)

IL-6 is dispensable for the suppressive activity of MDSC on primary CD4+ T-cell activation. IL-6 is dispensable for the suppressive activity of MDSC on.

Masanori Isogawa, Yoshihiro Furuichi, Francis V. Chisari Immunity

Volume 23, Issue 3, Pages (March 2015)

SOCS-1 Participates in Negative Regulation of LPS Responses

Volume 15, Issue 2, Pages (February 2007)

Volume 25, Issue 5, Pages (May 2017)

Volume 31, Issue 1, Pages (July 2009)

Volume 140, Issue 4, Pages (April 2011)

Volume 23, Issue 10, Pages (October 2015)

Dendritic Cells Transfected with Cytopathic Self-Replicating RNA Induce Crosspriming of CD8+ T Cells and Antiviral Immunity Vito Racanelli, Sven-Erik.

Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation

Human T cells undergoing apoptosis and necroptosis release mitochondria, and apoptotic mitochondria recruit neutrophils. Human T cells undergoing apoptosis.

Volume 13, Issue 6, Pages (December 2000)

Volume 39, Issue 6, Pages (December 2003)

Volume 29, Issue 6, Pages (December 2008)

HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress Nirmalya Sen, Rajni Kumari, Manika Indrajit.

Volume 147, Issue 4, Pages e8 (October 2014)

Molecular mechanism of STING-mediated inhibition of the mTORC1 pathway

Volume 22, Issue 2, Pages (February 2005)

Volume 11, Issue 4, Pages (April 2012)

RSV peptide library screen for candidate CD4+ T cell epitopes.

Volume 12, Issue 5, Pages (November 2005)

Volume 5, Issue 1, Pages (January 2009)

Volume 119, Issue 1, Pages (July 2000)

CTLA-4 Regulates Induction of Anergy In Vivo

Volume 8, Issue 2, Pages (August 2003)

Epicutaneous Application of CpG Oligodeoxynucleotides with Peptide or Protein Antigen Promotes the Generation of CTL Sandra K. Klimuk, Hossain M. Najar,

Ag 85A–specific immune responses.

Human T cells undergoing apoptosis and necroptosis release mitochondria, and apoptotic mitochondria recruit neutrophils. Human T cells undergoing apoptosis.

Peripheral CD8+ T Cell Tolerance Against Melanocytic Self-Antigens in the Skin Is Regulated in Two Steps by CD4+ T Cells and Local Inflammation: Implications.

A hypoallergenic cat vaccine based on Fel d 1–derived peptides fused to hepatitis B PreS Katarzyna Niespodziana, MSc, Margarete Focke-Tejkl, PhD, Birgit.

Volume 27, Issue 3, Pages (March 2019)

Volume 25, Issue 5, Pages (May 2017)

Fig. 7. Effect of CM from hASCs and melatonin-treated hASCs on protein expression in cisplatin-exposed HK-2 cells. HK-2 cells were exposed to cisplatin.

Volume 39, Issue 5, Pages (November 2013)

Figure 1. T-cell immunogenicity of HZ DNA vaccines in C57BL/6 mice

Immunization regimens that include a GLA-SE-formulated protein vaccine generate memory CD4 T cells. Immunization regimens that include a GLA-SE-formulated.

Fig. 8 C9orf72 knockdown results in an increase in autophagic flux.

5FU-induced specific activation of CD8+ T cells.

Volume 23, Issue 6, Pages (June 2015)

Immune response of CEA-transgenic mice transferred with OT-1 splenocytes and immunized with ovalbumin and adjuvant. Immune response of CEA-transgenic mice.

Immunization with IR or F/T elicits activated OT-I cells of distinct phenotypes. Immunization with IR or F/T elicits activated OT-I cells of distinct phenotypes.

Presentation transcript:

Anti-E1Anti-E2 rE1E2p7 protein VEE/SIN-E1E2P7 VEE/SIN-E1E rE1E2P7 protein VEE/SIN-E1E2P7 VEE/SIN-E1E2 EndoH r E1E2p7 protein) VEE/SIN-E1E2P7 r E1E2P7 protein VEE/SIN-E1E2P7 VEE/SIN-E1E2 EndoH VEE/SIN-NS345 * * * 70 Anti-NS3 rSOD-C33C (NS3) NS4A/B: 35 VEE/SIN-NS345 rSOD-C100 (NS4) Anti-NS4 57 VEE/SIN-NS345 rSOD-NS5 (NS5A/B) Anti-NS5AAnti-NS5B VEE/SIN-NS NS4B: 27 NS4A: 8 * * * * * * * * ** A B rE1E2p7 protein rSOD-NS5 (NS5A/B) Supplemental Fig. 1

Legend of supplemental Fig. 1 Detection of HCV protein expression from VEE/SIN replicon particles by Western blotting. A. Detection of E1 and E2 expression from the BHK cell lysates with VEE/SIN-E1E2 and VEE/SIN-E1E2p7 infection. VEE/SIN-NS345 is a negative control. rE1E2p7 protein is a positive control. The size was indicated corresponding to E1 (33-35kDa) and E2 (68-74kDa). EndoH: protein was treated with EndoH (Biolab) at 37ºC for 1 hour. B. Detection of NS3, NS4, NS5A and NS5B expression from the cell lysates with VEE/SIN-NS345 infection. rE1E2p7 is a negative control. SOD-C33C (a.a ), SOD-C100 (a.a ), and SOD-NS5 (a.a ) are recombinant proteins used as positive controls for the detection of NS3, NS4, NS5A and NS5B respectively. The size was indicated corresponding to NS3, NS4A, NS4B, NS4A/B, NS5A and NS5B. * Indicated the specific detection of the proteins.

CD4 IFN- CD8 PBS (1,2,3) IFN- E1E2/MF59 (1,2,3) E1E2/MF59/CpG (1,2,3) VEE/SIN-E1E2 (1,2,3) E1E2/MF59 (1,2) VEE/SIN-E1E2 (3) E1E2/MF59/CpG (1,2) VEE/SIN-E1E2 (3) PBS (1,2,3)E1E2/MF59 (1,2,3) E1E2/MF59/CpG (1,2,3) VEE/SIN-E1E2 (1,2,3) E1E2/MF59 (1,2) VEE/SIN-E1E2 (3) E1E2/MF59/CpG (1,2) VEE/SIN-E1E2 (3) AB Supplemental Fig. 2

Legend of supplemental Fig. 2 Detection of CD4 + and CD8 + T cells responses by ICS/FACS. BALB/c mice (n = 10) received three injections i.m. at 3-week intervals by the immunogens as indicated. The spleen cells were harvested 2 weeks after the last immunization and stimulated with 10 g/ml of HCV specific peptides for ICS and FACS analysis. The data are presented as dot plots of ICS for CD4 + and IFN- after E1 peptide pool stimulation (A) and for CD8 + and IFN- after CD8 E2 peptide stimulation (B). Significant responses are indicated by circles in the upper-right quadrant.

Supplemental Fig. 3 E1E2/MF59 (1,2,3) E1E2/MF59/CpG (1,2,3) VEE/SIN-E1E2 (1,2,3) VEE/SIN-E1E2 (1,2); E1E2/MF59 (3) VEE/SIN-E1E2 (1,2); E1E2/MF59/CpG (3) E1E2/MF59 (1,2); VEE/SIN-E1E2 (3) E1E2/MF59/CpG (1,2); VEE/SIN-E1E2 (3) PBS (1,2,3) *

Legend of supplemental Fig. 3 VEE/SIN-E1E2 immunization and Prime/boost regimen with E1E2/MF59 and VEE/SIN-E1E2 could stimulate good CD8 + T cells responses. BALB/c mice (n = 10) were received three injections i.m. at 3-week intervals by the immunogens as indicated. The spleen cells were harvested at 2 weeks after the last immunization and stimulated with 10 g/ml of HCV specific peptides for ICS and FACS analysis. 20-mer over-lapping peptide pools for HCV-1a E1 region (E1 pool) and E2 region (E2 pool), and single peptide to E2 for CD4 + T cells (CD4 E2 pep) and CD8 + T cells (CD8 E2 pep) were used for stimulation. The data are presented as mean total percentages of CD8 + IFN- + cells from two pools (five mice per pool). * P<0.05 as compared with PBS control group.